US FDA partially halts Sanofi’s Phase 3 tolebrutinib trial in US
The US FDA has paused new enrolment in the US and told the participants who have been enrolled…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
01 Jul 22
The US FDA has paused new enrolment in the US and told the participants who have been enrolled…
17 Jun 22
In the study, crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation…
13 Jun 22
The company’s investigational RSV vaccine candidate RSVPreF3 OA has showed statistically significant and clinically meaningful efficacy in adults…
31 May 22
Cialis is a PDE-5 inhibitor therapy that can be used to treat erectile dysfunction (ED), the signs and…
19 May 22
The Phase 1 clinical trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for…
12 May 22
The Phase 3 study evaluated the tiragolumab plus Tecentriq in 534 patients with first-line PD-L1-high metastatic non-small cell…
18 Apr 22
In the Phase 2/3 clinical trial in 140 children, a booster dose of Comirnaty has increased neutralizing antibodies…
05 Apr 22
AZD8233 is a novel, investigational ASO therapy designed to reduce blood cholesterol levels in patients with hypercholesterolemia (elevated…
10 Mar 22
The Phase 2/3 EPIC-PEDS study is designed to enrol around 140 paediatric participants, aged below 18 years of…
21 Feb 22
In the interim analysis, Dupixent showed positive results in reducing itch and hives (primary endpoints) but did not…